Taletrectinib: ROS1-positive lung cancer: consultation records checklist

1. Bring pathology, the ROS1 testing method and complete results to confirm the target and disease extent
2. List doses, dates and progression records for crizotinib and other previous medicines to assess subsequent options
3. Provide recent original chest and abdominal CT and brain MRI images to discuss brain and systemic lesions together
4. Prepare ECG, liver tests and all medicines to plan prescribing and ongoing monitoring

Questions to clarify
- Do I meet the eligibility criteria?
- What are the separate medical and coordination service costs without Chinese health insurance or free-drug assistance?
- How are initial treatment, ongoing treatment, return travel and follow-up arranged?
- Which risks require immediate contact with the hospital?

An initial service consultation does not replace medical assessment.